Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-tympanic dexamethasone for prevention of cisplatin-induced ototoxicity
PACTR201707002355147Recruiting
- Sponsor
- The College of Medicine
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dexamethasone in cisplatin-induced ototoxicity (2 arms), sponsored by The College of Medicine. Primary endpoint: Pure tone audiometry result. Started Jun 2017; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
cisplatin-induced ototoxicity
Beyond the preview
Go deeper on PACTR201707002355147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201707002355147.